Social listening can help medical affairs and medical information teams identify knowledge gaps, strengthen scientific exchange and respond to changing stakeholder needs faster and at greater scale.
Japan launch pricing has become more consequential against the backdrop of the U.S. most-favored-nation (MFN) policy. Japan is included in the reference basket contemplated under ...
Shionogi, Gate Bioscience, and Alector post a trio of new deals, Rajul Jain makes the case for social listening as a medical ...
The takeaway leadership message from our May issue is clear: Future progress will come from those willing to rethink the machinery — not just the medicine.
Trialbee CEO Matt Walz explores the current impact of AI in delivering practical gains in clinical development and reflects ...
Under terms of the agreement, IntraBio is expected to become a wholly owned subsidiary of Shionogi Inc., Shionogi's New Jersey-based subsidiary. 1 Shionogi Inc. will also acquire all outstanding ...
Logan Melchione shares how ClaimGuardRx gives account teams a fast, conversational way to tackle diversion and fraud together, and what that means for clients and patients. Biopharma manufacturers are ...
For years, health care professional (HCP) engagement has rested on a flawed assumption: that more information, delivered ...
Chris Learn, Ph.D., M.B.A., P.M.P., Senior Vice President, Head, Cell and Gene Therapy and Early Phase at Parexel, has helped guide more than 20 gene therapy programs ...
Why effective RWD linkage starts with a specific research objective — and how tokenization, clean rooms, and AI make it possible. Real-world data (RWD) is an essential resource for finding insights ...
CORXEL’s Dr. Bo Liang on why GLP-1 therapies are a broader chronic disease platform — not just obesity drugs — with benefits ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results